Evidence map›Paper›PMID 39143121›Full record

ArticleCell research2024

Accurate de novo design of heterochiral protein-protein interactions.

Ke Sun, Sicong Li, Bowen Zheng, Yanlei Zhu, Tongyue Wang, Mingfu Liang, Yue Yao, Kairan Zhang, Jizhong Zhang, Hongyong Li and 7 more

Abstract read
In one paragraph

Article in Cell research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Advances in Cyclic Peptides Targeting G Protein-Coupled Receptors.Chembiochem : a European journal of chemical biology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Protein design and RNA design: Perspectives.Quantitative biology (Beijing, China) · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ke Sun *College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Sicong Li *Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
Bowen Zheng *Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
Yanlei Zhu *Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
Tongyue Wang *Tsinghua-Peking Joint Center for Life Sciences, Ministry of Education Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Center for Synthetic and Systems Biology, Department of Chemistry, Tsinghua University, Beijing, China.
Mingfu LiangKey Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences and Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China.
Yue YaoWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
Kairan ZhangKey Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences and Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China.
Jizhong ZhangKey Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences and Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China.
Hongyong LiKey Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences and Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China.
Dongyang HanTsinghua-Peking Joint Center for Life Sciences, Ministry of Education Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Center for Synthetic and Systems Biology, Department of Chemistry, Tsinghua University, Beijing, China.
Jishen ZhengHefei National Laboratory for Physical Sciences at the Microscale, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China.ORCID 0000-0002-0781-2023
Brian CoventryDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Longxing CaoWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
David BakerDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Lei LiuTsinghua-Peking Joint Center for Life Sciences, Ministry of Education Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Center for Synthetic and Systems Biology, Department of Chemistry, Tsinghua University, Beijing, China. lliu@mail.tsinghua.edu.cn.ORCID 0000-0001-6290-8602
Peilong LuWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China. lupeilong@westlake.edu.cn.ORCID 0000-0001-5894-9268

Funding

China Postdoctoral Science Foundation 2021M692883Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2020YFA0909200National Natural Science Foundation of China (National Science Foundation of China) 22137005Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LR23C050001
6 · The paper itself

Abstract

Abiotic D-proteins that selectively bind to natural L-proteins have gained significant biotechnological interest. However, the underlying structural principles governing such heterochiral protein-protein interactions remain largely unknown. In this study, we present the de novo design of D-proteins consisting of 50-65 residues, aiming to target specific surface regions of L-proteins or L-peptides. Our designer D-protein binders exhibit nanomolar affinity toward an artificial L-peptide, as well as two naturally occurring proteins of therapeutic significance: the D5 domain of human tropomyosin receptor kinase A (TrkA) and human interleukin-6 (IL-6). Notably, these D-protein binders demonstrate high enantiomeric specificity and target specificity. In cell-based experiments, designer D-protein binders effectively inhibited the downstream signaling of TrkA and IL-6 with high potency. Moreover, these binders exhibited remarkable thermal stability and resistance to protease degradation. Crystal structure of the designed heterochiral D-protein-L-peptide complex, obtained at a resolution of 2.0 Å, closely resembled the design model, indicating that the computational method employed is highly accurate. Furthermore, the crystal structure provides valuable information regarding the interactions between helical L-peptides and D-proteins, particularly elucidating a novel mode of heterochiral helix-helix interactions. Leveraging the design of D-proteins specifically targeting L-peptides or L-proteins opens up avenues for systematic exploration of the mirror-image protein universe, paving the way for a diverse range of applications.

Indexed as

Interleukin-6Protein BindingReceptor, trkACrystallography, X-RayHumansModels, MolecularPeptidesSignal TransductionInterleukin-6NTRK1 protein, humanPeptidesReceptor, trkA

Identifiers

PMID39143121
PMCPMC11614891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.